LSECs have significant research uses in liver regeneration studies, in vitro toxicity testing and the clearance of pathogens and macromolecules.
New nomenclature for liver disease (NASH and NAFLD vs MASH and MASLD)
The liver diseases of nonalcoholic fatty liver disease (NAFLD) & nonalcoholic steatohepatitis (NASH) have changed names by a modified Delphi process.